🇺🇸 Nivolumab plus Platinum Doublet Chemotherapy in United States

Nivolumab plus Platinum Doublet Chemotherapy (Nivolumab plus Platinum Doublet Chemotherapy) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Nivolumab plus Platinum Doublet Chemotherapy in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Nivolumab plus Platinum Doublet Chemotherapy approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Nivolumab plus Platinum Doublet Chemotherapy in United States?

Galvanize Therapeutics, Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.